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Purpose: Excessive daytime sleepiness is highly prevalent in the general population, is the
hallmark of narcolepsy, and is linked to signiﬁcant morbidity. Clinical assessment of sleepi-
ness remains challenging and the common objective multiple sleep latency test (MSLT)
and subjective Epworth sleepiness scale (ESS) methods correlate poorly. We examined
the relative utility of pupillary unrest index (PUI) as an objective measure of sleepiness in a
group of unmedicated narcoleptics and healthy controls in a prospective, observational pilot
study. Methods: Narcolepsy (n= 20; untreated for >2weeks) and control (n = 56) partic-
ipants were tested under the same experimental conditions; overnight polysomnography
was performed on all participants, followed by a daytime testing protocol including: MSLT,
PUI, sleepiness visual analog scale (VAS), ESS, and the psychomotor vigilance test (PVT).
Results: The narcolepsy and control groups differed signiﬁcantly on psychomotor perfor-
mance and each measure of objective and subjective sleepiness, including PUI. Across
the entire sample, PUI correlated signiﬁcantly with objective (mean sleep latency, SL) and
subjective (ESS andVAS) sleepiness, but none of the sleepiness measures correlated with
performance (PVT). Among narcoleptics, VAS correlated with PVT measures. Within the
control group, mean PUI was the only objective sleepiness measure that correlated with
subjective sleepiness. Finally, in an ANCOVA model, SL and ESS were signiﬁcantly pre-
dictive of PUI as measure of sleepiness. Conclusion: The role of PUI in quantifying and
distinguishing sleepiness of narcolepsy from sleep-satiated healthy controls merits further
investigation as it is a portable, brief, and objective test.
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INTRODUCTION
Comprehensive clinical evaluation of excessive daytime sleepiness
(EDS) includes diagnostic testing to distinguish narcolepsy, 20%
of the sleep clinic population, from other primary sleep disorders
(Partinen and Hublin, 2000). Multiple sleep latency test (MSLT),
the de facto gold standard for objective measurement of sleepi-
ness and differential diagnosis of narcolepsy has several limitations
(Chervin et al., 1995; Johns, 2000; Littner et al., 2005), making it
unreliable as the sole indicator of manifest sleepiness in narcolepsy
(Kotterba et al., 2004; Wise, 2006).
Pupillometry is a brief, non-invasive, physiologically based
technique shown to concur with behavioral indicators of sleepi-
ness in several populations (Lichstein et al., 1994; Wilhelm et al.,
1998a, 2001, 2009; Wilhelm, 2008), including in narcolepsy, where
its use dates back several decades (Yoss et al., 1969, 1970). The
interpretation of pupillometry-derived measures of sleepiness is
limited by a lack of normative data and a robust“single-best”mea-
sure. Several pupillometry-derived measures of sleepiness, e.g.,
pupillary diameter and stability, pupillary light reﬂex have been
examined in narcolepsy with discrepant results (Kollarits et al.,
1982; Pressman et al., 1984; Norman and Dyer, 1987; O’Neill et al.,
1996).
Previous studies have investigated sleepiness-induced oscilla-
tions of pupil diameter pupillary unrest index (PUI) and its
relationship to sleep deprivation (Hertz et al., 1988), circadian
periodicity, and EEG (MSLT) parameters (Wilhelm et al., 1998a;
Wilhelm and Ludtke, 1999; Merritt et al., 2004). The potential role
of PUI in differentiating pathological sleepiness, particularly in
narcolepsy, relative to sleepiness associated with societal factors in
a normal control populationhas not been systematically evaluated.
The aims of this pilot study were (1) to evaluate the role of PUI
as an objective measure of sleepiness in distinguishing narcolepsy
from normal controls and (2) to understand the relationship of




A total of 76 participants (41 females and 38 males) were recruited
into this prospective observational study: 20 participants pre-
viously diagnosed with narcolepsy (14 females, 6 males, aged
33.8± 12.3 years, body mass index; BMI 24.3± 3.1 kg/m2, 13 with
cataplexy, 7 without cataplexy); and 56 normal controls from
the community (29 females, 27 males, aged 37.5± 11.1 years,
BMI 23.0± 2.7 kg/m2). The study was reviewed and approved by
the Institutional Research Board of the University of Illinois at
Chicago, and all participants provided written consent for their
participation and release of prior medical records. participants
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were 19–65 years of age; were negative on two urine drug screens
(initial intake evaluation and ﬁrst sleep laboratory visit); had
unremarkable results on urinalysis, blood chemistry, thyroid tests,
complete blood count, electrocardiogram (ECG), Beck depression
inventory, current medical history, physical examination; and had
normal pupil motility. A diagnosis of narcolepsy was made using
the American Academy of Sleep Medicine published MSLT crite-
ria: mean sleep latency (SL)< 8 min and at least two sleep onset
rapid eye movement periods (SOREMP; Littner et al., 2005). All
included participants reported attaining at least 7.5 h of sleep every
night on a 7-day sleep log for the week prior to the clinic visit and
for 1week immediately prior to sleepiness assessment. Normal
control participants that were included declared a usual daily caf-
feine intake of less than 500mg, did not have a shift work schedule,
and had no sleep complaints or primary sleep disorder identiﬁed
by polysomnography (PSG). All participants who were undergo-
ing treatment for any other conditions that might affect sleep (e.g.,
depression, antidepressant medication use) and participants with
Apnea Hypopnea Index>5 on PSG were excluded.
PROTOCOL
Narcolepsy participants already on treatment were required to
discontinue treatment with stimulant medications for a period
of at least 2 weeks prior to baseline measures, representing at
least ﬁve pharmacokinetic half-lives of the medications. While
most narcolepsy participants had been treated by modaﬁnil alone
(63%), fewer were taking methylphenidate (26%), or both med-
ications (11%). A sleep assessment comprised of the following:
participants reported to the sleep laboratory at 8:00 p.m. and
overnight PSG was performed using a standard clinical montage:
EEG, electrooculogram (EOG), electromyogram (EMG, chin and
lower extremities), ECG, respiration, oxygen saturation, and snore
microphone. Lights-out time was between 10:00 p.m. and 11:00
p.m. and lights-on the following morning was at about 7:00 a.m.
Participants were served breakfast and lunch, but were not per-
mitted to consume beverages or foods containing caffeine during
the testing day following PSG.
Figure 1 depicts the daytime testing timeline. Four 11-min PUI
measurements during a pupillometry sleepiness test (PST) session,
two 10-minpsychomotor vigilance test (PVT)measurements (ﬁrst
in the morning and second in the afternoon), and four MSLT nap
opportunities were provided per standard recommended clinical
protocol across the day (Littner et al., 2005). A total of eight visual
analog scale (VAS) tests were administered (before and after each
of four PUI measures). The Epworth sleepiness scale (ESS) was
administered once, after a randomly chosen PST session.
A basic pupillary examination was conducted before the ﬁrst
PST, which was conducted in accordance with published recom-
mendations (Wilhelm et al., 1996). The pupil image of the partic-
ipant’s “dominant” eye (determined by the participant’s answer to
the History Questionnaire) was recorded. Prior to PUI measure-
ment, the participant wore infrared goggles for 8 min to facilitate
dark adaptation. The participant was seated quietly in a com-
fortable chair with their head stabilized by a chinrest, and was
instructed to relax and focus on a light-emitting diode directly
in front of them. Pupil diameters were continuously recorded
in real time with a portable electronic pupillometer (AMTech,
Weinheim, Germany) for 11min. Customized software enabled
graphic display of pupil behavior in eight 82-s epochs and calcu-
lation of the power spectrum of up to 0.8Hz as well as calculation
of PUI for each epoch. To calculate the PUI the average of 16
consecutive values for the 25-Hz data was derived. Because PUI
summarizes change in pupil size over time it is useful for inter-
individual comparison. Details of this methodology have been
published (Wilhelm et al., 1998b).
A 10-min PVT-192 for sustained attention was conducted two
times (in the morning and afternoon). This was done on a hand-
held device (Ambulatory Monitoring, Inc.,Ardsley,NY,USA) with
a 1-min practice exercise before each 10min test session. The pri-
mary PVT measure variables assessed in the study were (1) the
median reaction time (MRT) in each trial, and (2) the frequency
of lapses (RT> 500 ms); instances where the participant failed to
respond to in a timely manner to the stimulus.
The ESS is a self-administered questionnaire used to estimate
sleepiness for eight different real-life situations and reﬂects on
individual sleep propensity (Johns, 1991). The VAS for sleepiness
(Schneider et al., 2004) is a subjective scale on a 10-cm line, with
the left end or 0 being “asleep” and the right end or 10 being “as
awake as I can be.”
DATA ANALYSIS
Datawere analyzedusing SAS (version 9.2,SAS Institute,Cary,NC,
USA), and a p-value of<0.05was considered signiﬁcant. Outcome
variables were examined for normality and appropriate transfor-
mations using Box–Cox method (Box and cox, 1964) were used
to achieve normal distribution as applicable. A log transformation
was used for PUI, a square transformation for VAS, and an inverse
square root transformation for PVT MRT. All statistical analyses
were performed on transformed variables when applicable (PUI,
VAS, and PVT MRT). Tukey–Kramer multiple comparisons cor-
rection was performed for group differences. Pearson correlations
and ANCOVA were used to assess the relationship of PUI to other
measures of sleepiness and vigilance-performance,with each indi-
vidual measure utilized separately as a covariate in addition to the
group variable. Finally, receiver operating characteristic (ROC)
analysis was performed to test the utility of PUI in distinguishing
narcolepsy from controls and optimal point of PUI using Euclid-
ian distances was obtained. We examined the time-of-day effects
of the repeated measures (SL, PUI, andVAS), but in order to iden-
tify the inter-individual and between-group differences, we chose
to conduct further analysis on mean scores.
RESULTS
Descriptive statistics on all outcome measures in both groups are
provided in Table 2. ANOVA analyses revealed that all perfor-
mance and sleepiness measures, including PUI, in participants
with narcolepsy were different from controls. Selected Pearson’s
correlation coefﬁcient’s for outcomes are noted in ??. Consid-
ering the entire participant sample (n = 76), all objective and
subjective measures of sleepiness correlated signiﬁcantly with
each other while exhibiting no correlation with the vigilance-
performance measures. The correlation coefﬁcient’s between PUI
and SL (r =−0.27, p = 0.04) and PUI and VAS (r =−0.27;
p = 0.04) were signiﬁcant in the control group. In contrast, SL
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FIGURE 1 | Protocol for daytime tests.
Table 1 | Descriptive statistics and differences in measures between
groups.
Variable Narcolepsy, n= 20 Control, n= 56 #p-value
*PUI 11.48± 3.97 7.77± 2.66 <0.0001
SL 4.74± 3.30 11.85± 5.22 <0.0001
ESS 15.42± 20.70 5.73± 2.95 <0.0001
*VAS 4.97± 1.87 7.55± 1.51 <0.0001
*PVT MRT 244.58± 31.20 231.17± 38.31 0.02
PVT lapse 2.15± 3.13 1.20± 4.33 0.01
Data presented as mean±SD (untransformed data).
*Transformation performed for non-normal distributions prior to all analyses.
#Parametric tests were performed on all outcomes and Tukey–Kramer method
was used to correct for multiple comparisons.
*PUI, pupillary unrest index; SL, mean sleep latency; ESS, Epworth sleepiness
scale, *VAS, visual analog sleepiness scale.
*PVT MRT: average PVT median reaction time.
PVT lapse: average PVT lapses.
did not exhibit any signiﬁcant relationship with subjective sleepi-
ness or vigilance-performance in controls. Within the narcolepsy
group, neither PUI nor SL exhibited any signiﬁcant correlation
with subjective sleepiness, with vigilance-performance, or with
each other. However subjective sleepiness (measured by VAS) was
signiﬁcantly correlated with vigilance-performance in narcolepsy.
To evaluate the relationship of PUI to other outcome mea-
sures, we performed multiple ANCOVA analyses (see Table 3);
in each case with PUI as an outcome variable, participant group
as predictor variable and each of the other measures individu-
ally as covariates (SL, ESS, VAS, PVT MRT, and PVT Lapse). The
appropriateness of the ANCOVA model for these analyses was
conﬁrmed previously by testing any signiﬁcant group and each
outcome variable interaction effects with multiple linear regres-
sion. No signiﬁcant group and outcome measure interactions were
found for any of the ﬁve measures (covariates speciﬁed above).
Overall, group effects onPUI remained signiﬁcantwhen eachmea-
sure was individually considered with the exception of ESS. When
Table 2 | Selected group-wise Pearson correlation coefficients and
p-value’s.
All study subjects; n= 76 Narcolepsy; n= 20 Controls; n= 56
*PUI and SL *PUI and SL *PUI and SL
r =−0.47 r =−0.40 r =−0.27
p =<0.0001 p = 0.07 p = 0.04
*PUI and ESS *PUI and ESS *PUI and ESS
r = 0.52 r = 0.37 r = 0.25
p =<0.0001 p = 0.11 p = 0.05
*PUI and *VAS *PUI and *VAS *PUI and *VAS
r =−0.40 r =−0.01 r =−0.27
p = 0.0003 p = 0.95 p= 0.04
SL and ESS ESS and *PVT MRT ESS and *VAS
r =−0.50 r = 0.39 r =−0.31
p =<0.0001 p = 0.09 p = 0.01
SL and *VAS *VAS and *PVT MRT
r = 0.38 r =−0.64 –
p = 0.0006 p = 0.002 –
ESS and *VAS *VAS and PVT lapse
r =−0.59 r =−0.43 –
p <0.0001 p = 0.05 –
All signiﬁcant p-values are in highlighted in bold font.
*PUI, pupillary unrest index; SL, mean sleep latency; ESS, Epworth sleepiness
scale; *VAS, visual analog sleepiness scale; *PVTMRT, average PVTmedian reac-
tion time; PVT lapse, average PVT lapses.
*Analyses on transformed data.
ESS was added to the model, the group effect on PUI was dimin-
ished and rendered insigniﬁcant. SL and ESS were the covariates
noted to be signiﬁcantly predictive of PUI.
To understand the potential utility of PUI to discriminate nar-
colepsy participants from healthy control’s we performed ROC
curve analyses. The area under the curve (AUC) for PUI was
0.79 (Figure A1 in Appendix), while consistent with previously
published reports (Johns, 2000) AUC for ESS (0.94) and SL (0.86)
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Table 3 | Prediction of PUI by group and other measure.
Predictor Parameter estimate p-Value
Group effect 2.41 0.02
SL −0.18 0.004
Group effect 1.56 0.33
ESS 0.23 0.02
Group effect 0.32 0.004
*VAS −0.02 0.23
Group effect 3.64 <0.0001
*PVT MRT 0.0013 0.80
Group effect 3.67 <0.0001
PVT lapse −0.01 0.89
ANCOVA analyses: *PUI is dependent variable, group (referent group control’s vs.
Narcoleptic’s) as predictor variable and each measure effect assessed individually
as covariate. All signiﬁcant p-values are in highlighted in bold font.
*PUI, pupillary unrest index; SL, mean sleep latency; ESS, Epworth sleepiness
scale; *VAS, visual analog sleepiness scale; *PVTMRT, average PVTmedian reac-
tion time; PVT lapse, average PVT lapses.
*Analyses on transformed data.
was higher. PUI at 9.5 mm/min had a sensitivity of 0.65 and
speciﬁcity of 0.78.
DISCUSSION
Pupillometry is reproducible, devoid of motivational inﬂuences
when performed under controlled circumstances (Wilhelm et al.,
1996), and automated quantiﬁcation permits elimination of inter-
observer variability.However,previous investigations of pupillom-
etry for assessment of narcolepsy have yielded conﬂicting results
(Schmidt, 1982) and thus far a single-best pupillometry-derived
index of pathologic sleepiness has not been identiﬁed. The poten-
tial utility of PUI has been suggested in narcolepsy (Newman and
Broughton, 1991; Wilhelm et al., 1998b). The result of the present
pilot study show that the PUI behaved in a manner equivalent to
the current clinical standard objective sleepiness assessment tool:
the MSLT. Further, PUI and SL were signiﬁcantly correlated and
showed similar patterns of correlation to measures of subjective
sleepiness and vigilance-performance. These ﬁndings support the
view that pupillary dynamics provide an objective biomarker of
sleepiness in narcolepsy.
Within the overall sample (n = 76) the correlation between PUI
and SLwas similar to the value reported byMcLaren et al. (2002) in
a mixed group of controls and patients with narcolepsy, idiopathic
hypersomnia, and poor sleep hygiene. However, because the mean
values of each of these measures in our sample differed between
narcolepsy and control participants, the overall correlations may
be inﬂated.
Objective sleepiness quantiﬁed by SL was not associated with
subjective sleepiness in either group considered separately. In con-
trast, PUI correlated SL, ESS, and VAS, indicating concordance
with self-reported sleepiness in this presumably sleep-satiated,
healthy control group. This discrepancy between objective sleepi-
ness measures in the control group may be due to the differential
sensitivity of PUI and SL to motivational inﬂuences or to a ceiling
effect of SL, where the relationship of SL to subjective sleepiness
degrades as SL increases (Chua et al., 1998). Among narcoleptic
participants, PUI correlated with SL in a fashion similar to con-
trols, but this did not achieve statistical signiﬁcance likely due to
sample size limitation and the poor sensitivity of SL to detect
severe degrees of sleepiness (ﬂoor effect). Vigilance-performance
was signiﬁcantly correlated only to VAS within the narcolepsy
group. Current clinical tests for objective quantiﬁcation of sleepi-
ness and wakefulness (MSLT and maintenance of wakefulness test;
MWT, respectively) are known to be poor surrogates for perfor-
mance prediction (Arand et al., 2005). Our results support no
advantage of pupillometry in this regard either in the setting
of narcolepsy or in the absence of pathologic sleepiness. Nar-
colepsy is associated with autonomic nervous system dysfunction
(Hublin et al., 1994) and it is not known if the elevation of PUI
among narcoleptics may be inﬂuenced by autonomic neuropa-
thy in addition to alertness state. The narcolepsy participants in
this study were previously diagnosed and treated (amphetamines
and/or modaﬁnil). Although, the treatment withdrawal was phar-
macokinetically adequate (2 weeks ormore), the long-term impact
of narcolepsy with or without cataplexy, on pupillary function
remains unknown and requires further investigation.A strong cor-
relation between vigilance-performance and VAS has previously
been shown in the setting of pathologic sleepiness, i.e., simulated
shift work (Tremaine et al., 2010). Our study shows VAS may be a
useful measure to predict performance in narcolepsy, particularly
if this ability to self-monitor is maintained with treatment.
Notably, within the control group, 12/56 participants (21%)
had a mean SL of ≤8 min and maybe considered “pathologi-
cally sleepy.” Only one participant in this sub-group had a single
SOREMPat the third (1 p.m.) nap opportunity.With lack of objec-
tive habitual sleep time monitoring (Actigraphy), the reason for
this pathologic sleepiness in the absence of any identiﬁable pri-
mary sleep disorder is uncertain. Possible explanations are ﬁrst
night effect leading to degraded sleep architecture on the preced-
ing nocturnal in-laboratory study or chronic behavioral-induced
insufﬁcient sleep syndrome (BIISS). The high prevalence of BIISS
(Komada et al., 2008) and its impact on mean SL has been previ-
ously reported (Janjua et al., 2003; Marti et al., 2009). We found
a negative correlation between total sleep time (TST) on the
preceding nocturnal PSG and mean SL on the following MSLT
(r =−0.37; p = 0.005) in the control group as has been previ-
ously reported (Bonnet andArand, 1995). This has been attributed
to the “high and low sleepability” or individual ability to tran-
sition to sleep; by Arand et al. (2005), and may partly account
for our observations. This “sleepy control” sub-group, deﬁned by
their low SL,was indistinguishable from“non-sleepy”normal con-
trols on subjective sleepiness scores (ESS and VAS) and their PUI
measurements were similar (see Table A1 in Appendix). Their
vigilance-performance was intermediate (between narcolepsy and
non-sleepy controls) and not signiﬁcantly different from either.
This suggests that PUI may be relatively devoid of trait “sleep-
ability” inﬂuences, a potential advantage over mean SL alone in
disease-free populations.
Pupillary unrest indexwas signiﬁcantly predicted by SL andESS
(tests currently utilized in clinical practice), independent of group
effects. However, the ROC analyses on ESS and SL conﬁrmed their
superiority over PUI as single screening and diagnostic tools for
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the diagnosis of suspected narcolepsy. Factors such as presence of
cataplexy, preceding duration of disease, age, and treatment his-
tory may inﬂuence the diagnostic accuracy of the PUI in a fashion
that cannot be determined in this small group of participants with
narcolepsy.
LIMITATIONS
This study includes a heterogeneous group of narcoleptics (with
and without cataplexy), where the underlying neurophysiologic
substrates and mechanisms are distinct (Ahmed and Thorpy,
2010). Additionally, it has recently been shown that Orexin-A,
primarily deﬁcient in narcolepsy with cataplexy, modulates pupil
size (Schreyer et al., 2009) and maybe a marker of hypocretin
deﬁciency rather than a measure of alertness alone in narcolepsy
with cataplexy (Plazzi et al., 2011). The presence of cataplexy, age
of onset, durations of disease, prior treatment or lack thereof
to account for potential direct and indirect effects of drugs on
pupil size should be considered in future studies. Other limita-
tions include a single baseline PSG for all participants (potential
ﬁrst night effect) and subjective assessment of habitual sleep
time. We found signiﬁcant time-of-day effects within individu-
als on all of the repeated measures: MSLT, PST, and VAS. The
susceptibility of all of these tests to circadian effects has been pre-
viously reported (Kraemer et al., 2000; Danker-Hopfe et al., 2001).
However, in order to examine the inter-individual trait differ-
ences and between-groups relationships we chose mean scores for
further analysis. Examination and comparison of circadian effects
on these instruments will better deﬁne the role of pupillometry
in narcolepsy.
CONCLUSION
These results show that PUI distinguishes pathologic sleepiness
of narcolepsy and is an accurate indicator of sleep propensity in
controls. Pupillometry cannot substitute for the MSLT as a diag-
nostic tool in narcolepsy. However, given that the pupillometer is
portable, the test protocol is short and the available metrics are
reproducible without learning effects, tracking changes in PUI (or
related indices) may prove to have value for longitudinal assess-
ment in narcolepsy. It will be important for future studies to
address the direct effects of modaﬁnil and other approveddrugs on
pupillary dynamics and to directly examine longitudinal reliability
and utility of these measures.
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APPENDIX
Table A1 | Comparisons of sleepy control sub-group on outcomes.
Outcome Group
Sleepy control (n= 12) vs.
Narcolepsy (n= 20)
Sleepy control (n= 12) vs.
Non-sleepy control (n= 44)
Narcolepsy (n= 20) vs.
Non-sleepy control (n= 44)
*PUI p = 0.08 p = 0.30 p < 0.0001
SL p = 0.90 p< 0.0001 p< 0.0001
ESS p < 0.0001 p = 0.82 p < 0.0001
*VAS p = 0.001 p = 0.84 p< 0.0001
*PVT MRT p = 0.10 p = 0.90 p = 0.08
PVT lapse p = 0.13 p = 0.64 p = 0.02
General linear model were performed; t-statistic with corresponding p-values are presented with Tukey–Kramer correction for multiple comparisons. Signiﬁcant p-
values are highlighted in bold font. SL data sub-group comparisons reﬂect the cut-off values chosen to deﬁne normal threshold value of 8min or more.
*PUI, pupillary unrest index; SL, mean sleep latency; ESS, Epworth sleepiness scale; *VAS, visual analog sleepiness scale; *PVT MRT, average PVT median reaction
time; PVT lapse, average PVT lapses.
*Analyses on transformed data.
FIGUREA1 | Receiver operating characteristic curve for log PUI.
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